Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
Clinical trial NCT03841734 · COMPLETED
Trial details
- NCT number
- NCT03841734
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2023-07-26
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.